CBOE
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2025 |
|---|---|
| Revenue | — |
| Gross profit | — |
| Operating income | — |
| Net income | -$36.0M |
| Diluted EPS | — |
| Operating cash flow | — |
| Free cash flow | — |
| Gross margin | — |
| Operating margin | — |
| Net margin | — |
| Line item | Q1 '25 | Q3 '25 | Q1 '26 |
|---|---|---|---|
| Revenue | — | — | — |
| Gross profit | — | — | — |
| Operating income | — | — | — |
| Net income | $32,164.00 | $54.7M | -$52.3M |
| Diluted EPS | — | — | — |
| Operating cash flow | — | — | — |
| Free cash flow | — | — | — |
| Gross margin | — | — | — |
| Operating margin | — | — | — |
| Net margin | — | — | — |
Headlines for TOXR will appear here once the news feed is connected.
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.